Imaging and Physiologic Evaluation of Coronary Artery Disease
NCT ID: NCT05124249
Last Updated: 2025-02-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2000 participants
OBSERVATIONAL
2021-11-01
2028-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Incheon-Bucheon Cohort of Patients Undergoing Primary PCI for Acute STEMI
NCT02804958
Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study
NCT05860400
Platelet Indices in Patients Undergoing Primary PCI and Its Prognostic Value
NCT04290949
Prognostic Implications of Physiologic Investigation After Revascularization With Stent
NCT04684043
Precision Therapy in Complex High-risk Coronary Artery Disease
NCT04444960
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this regard, intravascular imaging, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), is a useful tool for assessing the anatomical severity in more detail. Those imaging modalities produce cross-sectional images of CAD and imaging modalities are allowing to assess lesion characteristics, plaque morphology, treatment planning, and optimization of the implanted stent. Furthermore, imaging-guided percutaneous coronary intervention (PCI) has been shown favorable outcomes, compared with angiography only-guided PCI, especially in complex lesions. Meanwhile, there has been an ample body of evidence that invasive coronary physiology assessment, such as fractional flow reserve (FFR), also can be useful for assessing the functional significance. Therefore, the current guidelines have continuously recommended intracoronary imaging and invasive physiologic assessment for guiding the treatment of CAD.
The aim of the IP-CAD (Imaging and Physiologic Evaluation of Coronary Artery Disease: a Prospective Registry Study) is to evaluate the long-term clinical outcomes according to the imaging-guided or physiology-guided PCI in real-world practice.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Invasive coronary angiography (ICA)
Patients who undergoing invasive coronary angiography with intravascular imaging or invasive physiologic assessment
Intravascular imaging (IVUS or OCT) or Invasive physiologic assessment
Intravascular imaging (IVUS or OCT) or Invasive physiologic assessment
Percutaneous coronary intervention (PCI)
Patients who undergoing percutaneous coronary intervention with intravascular imaging or invasive physiologic assessment
Intravascular imaging (IVUS or OCT) or Invasive physiologic assessment
Intravascular imaging (IVUS or OCT) or Invasive physiologic assessment
PCI
Patients who undergoing PCI
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intravascular imaging (IVUS or OCT) or Invasive physiologic assessment
Intravascular imaging (IVUS or OCT) or Invasive physiologic assessment
PCI
Patients who undergoing PCI
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects who suspected ischemic heart disease and underwent ICA.
* Subjects who were performed intravascular imaging or invasive physiologic assessment
Exclusion Criteria
* Pregnant women
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chonnam National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Young Joon Hong
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Young Joon LeeHong, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Chonnam National University Medical School; Chonnam National University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chonnam National University Hospital
Gwangju, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CNUH-2021-314
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.